Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Kedudukan dalam Saham #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Harga Saham
$481.73
Modal Pasaran
$377.65B
Perubahan (1 hari)
-0.96%
Perubahan (1 tahun)
50.07%
Negara
CH
Perdagangan Roche Holding AG (RO)

Kategori

Hasil untuk Roche Holding AG (RO)
Hasil pada Dec 2025 TTM: $77.52B
Menurut laporan kewangan terkini daripada Roche Holding AG, hasil semasa syarikat (TTM) ialah $77.52B. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Roche Holding AG dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$79.67B 2.77%
US
$97.93B 26.33%
US
$64.39B -16.94%
US
$66.40B -14.34%
US
$56.26B -27.43%
CH